NCT04635501View on ClinicalTrials.gov

AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 23, 2020

Primary Completion Date

May 5, 2021

Study Completion Date

June 7, 2021

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

ABS 5.6.7

Patients whose access site will be closed with the ABS 5.6.7

Trial Locations (2)

9200

A.Z. Sint-Blasius, Dendermonde

9300

O.L.V. Hospital, Aalst

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
collaborator

CyndRx, LLC

INDUSTRY

lead

ID3 Medical

OTHER

NCT04635501 - AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial | Biotech Hunter | Biotech Hunter